Companies
Swiftscale Biotherapeutics
rapid CFPS — DNA→protein in 24 h (personalised oncology).
- Country
- United States
FDA
Coverage
| CN | EU | US | |
|---|---|---|---|
| foundries-design | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Founded | 2019 | invo.northwestern.edu |
| Headquarters | South San Francisco, California | bizjournals.com |
| Headcount | 10-50 employees medium confidence | synapse.patsnap.com |
| Funding | Grant & Funding (NIH); acquired by Resilience medium confidence | synapse.patsnap.com |
| Production site | San Leandro, California (pilot plant); planned Oakland, California expansion | resilience.com · bizjournals.com · businesswire.com |
Independent sources: bizjournals.com · businesswire.com · invo.northwestern.edu · resilience.com · synapse.patsnap.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Cell-free systems & cell-free bioproduction | foundries-design | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.